Email Editor Several months of guessing ended this month when Mylan Laboratories (NYSE: MYL) announced a deal to buy Merck KGaA’s (DE: MRCG) generic pharmaceutical business for $6.7 billion (€4.9 billion) in cash. In so doing, Mylan beat out a number of competitors to...
The month of May saw the announcement of 72 mergers and acquisitions in the 13 sectors of the health care industry. The four sectors of the health care technology segment accounted for 38 of those transactions, or 53% of the total, while the nine sectors of the health...
A Florida CCRC Sets A New High Mark Throughout the years there have been very good properties that have sold, some extremely good ones and the exceptional few, but rarely in the CCRC market. For the past decade, most CCRCs that come to market are being sold because of...
IPO Priced, And The Ensign Group Files For Its IPO Timing is everything, and right now is a good time to own a skilled nursing facility or, better yet, a portfolio of nursing facilities. All one has to do is look at what happened with the auction of Genesis HealthCare...